REAP Financial Group LLC Boosts Stock Position in Synopsys, Inc. $SNPS

REAP Financial Group LLC boosted its holdings in Synopsys, Inc. (NASDAQ:SNPS) by 182.1% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 237 shares of the semiconductor company’s stock after acquiring an additional 153 shares during the period. REAP Financial Group LLC’s holdings in Synopsys were worth $121,000 at the end of the most recent reporting period.

Other large investors have also recently added to or reduced their stakes in the company. Vanguard Group Inc. lifted its stake in Synopsys by 2.4% during the first quarter. Vanguard Group Inc. now owns 14,829,770 shares of the semiconductor company’s stock worth $6,359,747,000 after purchasing an additional 346,994 shares in the last quarter. Pictet Asset Management Holding SA lifted its stake in Synopsys by 38.3% during the first quarter. Pictet Asset Management Holding SA now owns 2,432,596 shares of the semiconductor company’s stock worth $1,043,518,000 after purchasing an additional 673,837 shares in the last quarter. Ameriprise Financial Inc. lifted its stake in Synopsys by 6.6% during the first quarter. Ameriprise Financial Inc. now owns 2,013,380 shares of the semiconductor company’s stock worth $863,500,000 after purchasing an additional 125,199 shares in the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC increased its position in shares of Synopsys by 20.2% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 1,816,319 shares of the semiconductor company’s stock worth $778,928,000 after acquiring an additional 305,489 shares during the period. Finally, Alliancebernstein L.P. increased its position in shares of Synopsys by 22.2% during the first quarter. Alliancebernstein L.P. now owns 1,725,211 shares of the semiconductor company’s stock worth $739,857,000 after acquiring an additional 313,218 shares during the period. 85.47% of the stock is currently owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

SNPS has been the topic of a number of recent research reports. Baird R W lowered Synopsys from a “strong-buy” rating to a “hold” rating in a research report on Wednesday, September 10th. Wall Street Zen lowered Synopsys from a “hold” rating to a “sell” rating in a research report on Saturday, September 13th. Morgan Stanley cut their price objective on Synopsys from $715.00 to $510.00 and set an “overweight” rating on the stock in a research report on Thursday, September 11th. JPMorgan Chase & Co. cut their price objective on Synopsys from $685.00 to $600.00 and set an “overweight” rating on the stock in a research report on Wednesday, September 10th. Finally, Stifel Nicolaus cut their price objective on Synopsys from $650.00 to $550.00 and set a “buy” rating on the stock in a research report on Wednesday, September 10th. Eleven equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus target price of $575.31.

Insiders Place Their Bets

In other Synopsys news, Director Robert G. Painter bought 350 shares of the company’s stock in a transaction that occurred on Thursday, September 11th. The shares were purchased at an average price of $425.44 per share, with a total value of $148,904.00. Following the completion of the acquisition, the director directly owned 2,291 shares of the company’s stock, valued at $974,683.04. This represents a 18.03% increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CFO Shelagh Glaser sold 3,655 shares of the stock in a transaction on Friday, September 5th. The shares were sold at an average price of $609.77, for a total value of $2,228,709.35. Following the completion of the transaction, the chief financial officer directly owned 15,317 shares in the company, valued at $9,339,847.09. This trade represents a 19.27% decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 30,894 shares of company stock worth $16,760,783. 0.62% of the stock is owned by corporate insiders.

Synopsys Stock Performance

NASDAQ:SNPS opened at $477.83 on Wednesday. The firm has a market capitalization of $88.76 billion, a PE ratio of 37.51, a price-to-earnings-growth ratio of 5.27 and a beta of 1.10. The business’s fifty day moving average price is $553.70 and its 200 day moving average price is $510.20. The company has a debt-to-equity ratio of 0.52, a current ratio of 1.62 and a quick ratio of 1.51. Synopsys, Inc. has a 12 month low of $365.74 and a 12 month high of $651.73.

About Synopsys

Synopsys, Inc provides electronic design automation software products used to design and test integrated circuits. It operates in three segments: Design Automation, Design IP, and Software Integrity. The company offers Digital and Custom IC Design solution that provides digital design implementation solutions; Verification solution that offers virtual prototyping, static and formal verification, simulation, emulation, field programmable gate array (FPGA)-based prototyping, and debug solutions; and FPGA design products that are programmed to perform specific functions.